We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

40 hedge funds and large institutions have $124M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

14% more funds holding

Funds holding: 35 → 40 (+5)

11% more capital invested

Capital invested by funds: $112M → $124M (+$12M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
+$6.79M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$4.85M
3
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$4.85M
4
CF
Cantor Fitzgerald
New York
+$4.75M
5
Millennium Management
Millennium Management
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
FIG
Fortress Investment Group
New York
-$5.03M
2
SCM
Shaolin Capital Management
Florida
-$2.92M
3
UOC
UBS O'Connor
Illinois
-$2.51M
4
ACA
Arena Capital Advisors
California
-$933K
5
HighTower Advisors
HighTower Advisors
Illinois
-$877K
Name Holding Trade Value Shares
Change 		Change in
Stake
6CM
1
683 Capital Management
New York
$11.7M – – –
FTCM
2
Fir Tree Capital Management
New York
$9.77M +$4.88K +503 +0.1%
SCC
3
Spring Creek Capital
Kansas
$7.81M – – –
MI
4
MMCAP International
Cayman Islands
$7.79M – – –
LA
5
Linden Advisors
New York
$6.82M +$6.79M +700,000 New
CSS
6
Cubist Systematic Strategies
Connecticut
$6.18M -$1.5K -155 -0%
PC
7
Periscope Capital
Ontario, Canada
$5.84M -$2.91K -300 -0.1%
ACA
8
Arena Capital Advisors
California
$4.91M -$933K -96,166 -16%
ACM
9
Atalaya Capital Management
New York
$4.88M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
10
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.88M +$4.85M +500,000 New
KC
11
Kepos Capital
New York
$4.87M – – –
PSAMP
12
P. Schoenfeld Asset Management (PSAM)
New York
$4.87M +$4.85M +500,000 New
HighTower Advisors
13
HighTower Advisors
Illinois
$4.77M -$877K -90,350 -16%
CF
14
Cantor Fitzgerald
New York
$4.77M +$4.75M +489,286 New
RCM
15
Radcliffe Capital Management
Pennsylvania
$3.89M – – –
Millennium Management
16
Millennium Management
New York
$3.76M +$1.32M +135,614 +54%
AGC
17
Angelo Gordon & Co
New York
$2.92M – – –
Marshall Wace
18
Marshall Wace
United Kingdom
$2.68M – – –
SC
19
Sculptor Capital
New York
$2.44M – – –
SCM
20
Shaolin Capital Management
Florida
$2.16M -$2.92M -300,538 -58%
AA
21
AQR Arbitrage
Connecticut
$1.95M – – –
WRBC
22
W.R. Berkley Corp
Connecticut
$1.69M – – –
RCM
23
Rivernorth Capital Management
Florida
$1.68M -$28.5K -2,935 -2%
SCM
24
Segantii Capital Management
Hong Kong
$1.46M – – –
PMAM
25
Picton Mahoney Asset Management
Ontario, Canada
$1.46M – – –
1
2

ORIA Hedge Fund Activity: Q1 2022 in Review

40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q1 2022, worth a combined $124M — up 11% from $112M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ORIA positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was Linden Advisors, opening a new position worth an estimated $6.79M. The largest seller was Fortress Investment Group, exiting entirely with an estimated $5.03M sold.

  • 40 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q1 2022, up from 35 in Q4 2021.
  • Funds reported $124M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q1 2022, up 11% quarter-over-quarter.
  • 8 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q1 2022 and 3 closed out, a net change of +5 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q1 2022 was Linden Advisors, an estimated $6.79M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q1 2022 was Fortress Investment Group, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2022.